DURHAM, N.C., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc., a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, ...
Targets the global CRO market of $47.9 billion in 2025 and growing at 7% CAGR BERKELEY, Calif, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (PFSA), a commercial stage digital health company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results